A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN

✍ Scribed by F Patti; M.P Amato; M Filippi; P Gallo; M Trojano; G.C Comi

• Book ID: 119301437
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 72 KB
• Volume: 223
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/j.jns.2004.04.023